Phase 2 study of naxitamab in breast cancer, melanoma, sarcomas, small-cell lung cancer
Latest Information Update: 22 Dec 2021
At a glance
- Drugs Naxitamab (Primary)
- Indications Breast cancer; Malignant melanoma; Sarcoma; Small cell lung cancer
- Focus Therapeutic Use
- 22 Dec 2021 New trial record